Abstract
Cytostatic drugs are pharmaceutically active compounds used in chemotherapy to prevent or disrupt cell division. Only a few environmental studies have been focused on cytostatic drugs, in spite of their toxicity, their increasing consumption, and their discharge into municipal sewage. This fact can be mainly due to the lack of methods for their simultaneous analysis. This research describes the occurrence of 14 cytostatic drugs in influent and effluent wastewater from four wastewater treatment plants located in Seville (Spain) during 1-year period. A preliminary environmental risk assessment was also carried out. Five cytostatic drugs (cytarabine, etoposide, gemcitabine, iphosphamide, and methotrexate) were detected in influent wastewater at concentration levels up to 464 ng L−1 (cytarabine). Six of them (cytarabine, doxorubicin, gemcitabine, iphosphamide, paclitaxel, and vinorelbine) were detected in effluent wastewater at concentration levels up to 190 ng L−1 (cytarabine). Most of the detected cytostatic drugs are not significantly removed during wastewater treatment. Nevertheless, neither ecotoxicological nor genotoxical risks are expected to occur at the measured concentrations on the aquatic environment.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
Besse, J. P., Latour, J. F., & Garric, J. (2012). Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs? Environment International, 39, 73–86.
Buerge, I. J., Rudolfbuser, H., Poiger, T., & Muller, M. D. (2006). Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters. Environmental Science & Technology, 40, 7242–7250.
Camacho-Muñoz, M. D., Martín, J., Santos, J. L., Aparicio, I., & Alonso, E. (2010). Occurrence, temporal evolution and risk assessment of pharmaceutically active compounds in Doñana Park (Spain). Journal of Hazardous Materials, 183, 602–608.
Castiglioni, S., Bagnati, R., Calamari, D., Fanelli, R., & Zuccato, E. (2005). A multiresidue analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters. Journal of Chromatography A, 1092, 206–215.
Catastini, C., Mullot, J. U., Boukari, S., Mazellier, P., Levi, Y., Cervantes, P., et al. (2008). Assessment of antineoplastic drugs in effluents of two hospitals. Journal Europeen d’Hydrologie, 39(2), 171–180.
Cunningham, V. L., Binks, S. P., & Olson, M. J. (2009). Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. Regulatory Toxicology and Pharmacology, 53, 39–45.
Durán-Álvarez, J. C., Prado-Pano, B., & Jiménez-Cisneros, B. (2012). Sorption and desorption of carbamazepine, naproxen and triclosan in a soil irrigated with raw wastewater: estimation of the sorption parameters by considering the initial mass of the compounds in the soil. Chemosphere, 88(1), 84–90.
EMEA (2006). Guideline on the environmental risk assessment of medicinal products for human use. Doc. Ref. EMEA/CPMP/SWP/4447/00, London: European Agency for the Evaluation of Medicinal Products.
European Community (EC) (2003). Technical Guidance Document on Risk Assessment in support of Commission Directive 93/67/EEC on risk assessment for new notified substances, Commission Regulation (EC) no. 1488/94 on Risk Assessment for existing substances and Directive 98/8/EC of the European Parliament and of the council concerning the placing of biocidal products on the market, parts I, II and IV. European Communities, EUR 20418 EN/1.
FDA-CDER (1996). Retrospective review of ecotoxicity data submitted in environmental assessments. FDA Center for Drug Evaluation and Research, Rockville, MD, USA (Docket No. 96N–0057).
Ferk, F., Mišík, M., Grummt, T., Majer, B., Fuerhacker, M., Buchmann, C., et al. (2009). Genotoxic effects of wastewater from an oncological ward. Mutation Research, Genetic Toxicology and Environmental Mutagenesis, 672, 69–75.
Ferrando-Climet, L., Rodriguez-Mozaz, S., & Barceló, D. (2013). Development of a UPLC-MS/MS method for the determination of ten anticancer drugs in hospital and urban wastewaters, and its application for the screening of human metabolites assisted by information-dependent acquisition tool (IDA) in sewage samples. Analytical and Bioanalytical Chemistry, 405, 5937–5952.
Gómez-Canela, C., Cortés-Francisco, N., Oliva, X., Pujol, C., Ventura, F., Lacorte, S., et al. (2012). Occurrence of cyclophosphamide and epirubicin in wastewaters by direct injection analysis–liquid chromatography–high-resolution mass spectrometry. Environmental Science and Pollution Research, 19(8), 3210–3218.
Gómez-Canela, C., Cortés-Francisco, N., Ventura, F., Caixach, J., & Lacorte, S. (2013). Liquid chromatography coupled to tandem mass spectrometry and high resolution mass spectrometry as analytical tools to characterize multi-class cytostatic compounds. Journal of Chromatography A, 1276, 78–94.
Gracia-Lor, E., Sancho, J. V., Serrano, R., & Hernández, F. (2012). Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia. Chemosphere, 87(5), 453–462.
Johnson, A. C., Jürgens, M. D., Williams, R. J., Kümmerer, K., Kortenkamp, A., & Sumpter, J. P. (2008). Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study. Journal of Hydrology, 348(1–2), 167–175.
Kiffmeyer, T., Götze, H. J., Jursch, M., & Lüders, U. (1998). Trace enrichment, chromatographic separation and biodegradation of cytostatic compounds in surface water. Fresenius Journal of Analytical Chemistry, 361, 185–191.
Kosjek, T., & Heath, E. (2011). Occurrence, fate and determination of cytostatic pharmaceuticals in the environment. TrAC Trends in Analytical Chemistry, 30(7), 1065–1087.
Kovalova, L., Siegrist, H., Singer, H., Wittmer, A., & McArdell, C. S. (2012). Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environmental Science and Technology, 46, 1536–1545.
Kümmerer, K., & Al-Ahmad, A. (1997). Biodegradability of the anti-tumour agents 5-fluorouracil, cytarabine and gemcitabine: impact of the chemical structure and synergistic toxicity with hospital effluent. Acta Hydrochimica et Hydrobiologica, 25, 166–172.
Kümmerer, K., Steger-Hartmann, T., & Meyer, M. (1997). Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage. Water Research, 31(11), 2705–2710.
Llorente, M. T., Parra, J. M., Sánchez-Fortún, S., & Castaño, A. (2012). Cytotoxicity and genotoxicity of sewage treatment plant effluents in rainbow trout cells (RTG-2). Water Research, 46(19), 6351–6358.
Mahnik, S. N., Lenz, K., Weissenbacher, N., Mader, R. M., & Fuerhacker, M. (2007). Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. Chemosphere, 66, 30–37.
Martín, J., Camacho-Muñoz, M. D., Santos, J. L., Aparicio, I., & Alonso, E. (2011). Simultaneous determination of a selected group of cytostatic drugs in water using high-performance liquid chromatography–triple-quadrupole mass spectrometry. Journal of Separation Science, 34, 3166–3177.
Martín, J., Camacho-Muñoz, M. D., Santos, J. L., Aparicio, I., & Alonso, E. (2012). Distribution and temporal evolution of pharmaceutically active compounds alongside sewage sludge treatment. Risk assessment of sludge application onto soils. Journal of Environmental Management, 102, 18–25.
Matamoros, V., Arias, C. A., Nguyen, L. X., Salvadó, V., & Brix, H. (2012). Occurrence and behavior of emerging contaminants in surface water and a restored wetland. Chemosphere, 88, 1083–1089.
Negreira, N., López de Alda, M., & Barceló, D. (2013). On-line solid phase extraction–liquid chromatography–tandem mass spectrometry for the determination of 17 cytostatics and metabolites in waste, surface and ground water samples. Journal of Chromatography A, 1280, 64–74.
Reyes-Contreras, C., Hijosa-Valsero, M., Sidrach-Cardona, R., Bayona, J. M., & Bécares, E. (2012). Temporal evolution in PPCP removal from urban wastewater by constructed wetlands of different configuration: a medium-term study. Chemosphere, 88, 161–167.
Sanderson, H., Johnson, D. J., Wilson, C. J., Brain, R. A., & Solomon, K. R. (2003). Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicology Letters, 144(3), 383–395.
Steger-Hartmann, T., Kiimmerer, K., & Schecker, J. (1996). Trace analysis of the antineoplastics ifosfamide and cyclophosphamide in sewage water by two-step solid-phase extraction and gas chromatography–mass spectrometry. Journal of Chromatography A, 726, 179–184.
Steger-Hartmann, T., Kümmerer, K., & Hartmann, A. (1997). Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicology and Environmental Safety, 36, 174–179.
Verlicchi, P., Al Aukidy, M., & Zambello, E. (2012). Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment—a review. Science of the Total Environment, 429, 123–155.
Weigt, S., Huebler, N., Strecker, R., Braunbeck, T., & Broschard, T. H. (2011). Zebrafish (Danio rerio) embryos as a model for testing proteratogens. Toxicology, 281(1–3), 25–36.
Zhang, J., Chang, V. W. C., Giannis, A., & Wang, J. Y. (2013). Removal of cytostatic drugs from aquatic environment: a review. Science of the Total Environment, 445–446, 281–298.
Zounkova, R., Odraska, P., Dolezalova, L., Hilscherova, K., Marsalek, B., & Blaha, L. (2007). Ecotoxicity and genotoxicity assessment of cytostatic pharmaceuticals. Environmental Toxicology and Chemistry, 26(10), 2208–2214.
Zounkova, R., Kovalova, L., Blaha, L., & Dott, W. (2010). Ecotoxicity and genotoxicity assessment of cytotoxic antineoplastic drugs and their metabolites. Chemosphere, 81(2), 253–260.
Acknowledgments
The authors thank Andaluza de Tratamientos de Higiene S.A. (ATHISA) for its assistance in this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martín, J., Camacho-Muñoz, D., Santos, J.L. et al. Occurrence and Ecotoxicological Risk Assessment of 14 Cytostatic Drugs in Wastewater. Water Air Soil Pollut 225, 1896 (2014). https://doi.org/10.1007/s11270-014-1896-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11270-014-1896-y